Oncopeptides AB (0RN4) Revenue

2 Followers

Oncopeptides AB Revenue

Oncopeptides AB had a revenue of 31.10M in the quarter ending Jun 30, 2026, with 22.51%. This bring the company's revenue in the last twelve months to 95.26M, Decreased 14.30%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.

Revenue (ttm)

95.26M

Revenue Growth

87.23%

P/S Ratio

11.05

Revenue/Employee

kr1,030,696

Employees

Market Cap

kr785.60M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	71.12M	39.47M	+124.72%
Dec 31, 2024	31.65M	-3.57M	-10.14%
Dec 31, 2023	35.22M	26.86M	+321.54%
Dec 31, 2022	8.36M	-109.94M	-92.94%
Dec 31, 2021	118.30M	―	+∞%
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―